Phosphasal is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Biocomp Pharma. The primary component is Sodium Phosphate, Monobasic, Monohydrate; Phenyl Salicylate; Hyoscyamine Sulfate; Methylene Blue; Methenamine.
| Product ID | 44523-742_90b5fc2c-10d5-1adc-e053-2a95a90a311d |
| NDC | 44523-742 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Phosphasal |
| Generic Name | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, And Hyoscyamine Sulfate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2010-09-21 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | BioComp Pharma |
| Substance Name | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; PHENYL SALICYLATE; HYOSCYAMINE SULFATE; METHYLENE BLUE; METHENAMINE |
| Active Ingredient Strength | 41 mg/1; mg/1; mg/1; mg/1; mg/1 |
| Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Oxidation-Reduction Activity [MoA],Oxidation-Reduction Agent [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2010-09-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | unapproved drug other |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-09-21 |
| Ingredient | Strength |
|---|---|
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 40.8 mg/1 |
| SPL SET ID: | 90b5fc2c-10d4-1adc-e053-2a95a90a311d |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0076-0902 | Phosphasal | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 44523-742 | Phosphasal | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 0076-0111 | URIBEL | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 0178-0740 | URIBEL | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 0682-0334 | Urimar-T | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 79043-334 | Urimar-T | methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate |
| 54859-701 | Urin | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 79043-450 | URO-SP | Methenamine, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, and HYOSCYAMINE SULFATE |
| 0076-0903 | Ustell | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
| 44523-743 | Ustell | Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, Methylene Blue, and Hyoscyamine Sulfate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() PHOSPHASAL 85503898 4168084 Live/Registered |
BIOCOMP PHARMA, INC. 2011-12-27 |